Research / DAKT / Fundamental state Inspectable configuration
State dimensions Filing 0000915779-25-000061 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
28.44% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.81% · OPTIONAL · VALID
Operating cash generation 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
8.04% · OPTIONAL · VALID
Revenue growth 20th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-12.21% · CORE · VALID
Inventory pressure 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
75.38% · OPTIONAL · VALID
Gross margin 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
24.60% · CORE · VALID
Operating margin 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-2.43% · CORE · VALID
R&D intensity 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.31% · OPTIONAL · VALID
SBC intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.38% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 61 states Self-history eligible
Oct 30, 2021 8/8 normalized Level 3 Jan 29, 2022 8/8 normalized Level 3 Apr 30, 2022 8/8 normalized Level 3 Jul 30, 2022 8/8 normalized Level 3 Oct 29, 2022 8/8 normalized Level 3 Jan 28, 2023 8/8 normalized Level 3 Apr 29, 2023 8/8 normalized Level 3 Jul 29, 2023 8/9 normalized Level 3 Oct 28, 2023 8/9 normalized Level 3 Jan 27, 2024 8/9 normalized Level 3 Apr 27, 2024 8/9 normalized Level 3 Jul 27, 2024 8/9 normalized Level 3 Oct 26, 2024 8/9 normalized Level 3 Jan 25, 2025 8/9 normalized Level 3 Apr 26, 2025 8/9 normalized Level 3 Aug 2, 2025 9/9 normalized Level 3 Nov 1, 2025 9/9 normalized Level 3 Jan 31, 2026 9/9 normalized Level 3 May 2, 2026 9/9 normalized Level 3 Aug 1, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 31.39%
Current 28.44%
Delta -2.95% Capex Intensity Increased
Previous 2.58%
Current 2.81%
Delta 0.23% Cash Generation Decreased
Previous 20.80%
Current 8.04%
Delta -12.76% Growth Decreased
Previous 4.50%
Current -12.21%
Delta -16.71% Inventory Pressure Increased
Previous 58.36%
Current 75.38%
Delta 17.02% Margin Decreased
Previous 26.81%
Current 24.60%
Delta -2.21% Profitability Decreased
Previous 7.57%
Current -2.43%
Delta -10.00% R And D Intensity Increased
Previous 4.72%
Current 6.31%
Delta 1.59% Sbc Intensity Increased
Previous 0.25%
Current 0.38%
Delta 0.13% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.